HeartWare Gets 54-Patient Allotment For US Bridge-to-Transplant Clinical Trial RTT News HeartWare's ADVANCE clinical trial is an FDA approved IDE study designed to evaluate the HeartWare Ventricular Assist System as a bridge to heart transplantation for patients with end-stage heart failure. Under the ADVANCE study, 140 patients at 30 US ... |
